Please use this identifier to cite or link to this item: http://hdl.handle.net/10362/142606
Title: Therapeutic liquid formulations based on low transition temperature mixtures for the incorporation of anti-inflammatory drugs
Author: Roda, Ana
Paiva, Alexandre
Duarte, Ana Rita C.
Keywords: Celecoxib
LTTM
NSAID
Solubility
Therapeutic liquid formulations
Pharmaceutical Science
Issue Date: 5-Oct-2021
Citation: Roda, A., Paiva, A., & Duarte, A. R. C. (2021). Therapeutic liquid formulations based on low transition temperature mixtures for the incorporation of anti-inflammatory drugs. Pharmaceutics, 13(10), Article 1620. https://doi.org/10.3390/pharmaceutics13101620
Abstract: Most nonsteroidal anti-inflammatory drugs (NSAIDs) present poor aqueous solubility, impairing their efficiency in physiological media. In this context, Low Transition Temperature Mixtures (LTTMs) are a promising platform to overcome drugs’ poor solubility, forming therapeutic liquid formulations. In this work, the LTTMs of citric acid:L-arginine:water (C:A:W) and glyc-erol:sorbitol (G:S) were studied in terms of their features and assessed in terms of their ability to increase the solubility of six NSAIDs in physiological media. The physicochemical properties of LTTMs were characterized by state-of-art techniques commonly used for these systems. The cyto-toxicity of G:S was also evaluated in L929 mouse fibroblasts and the viscosity, polarity, and pH properties of the studied mixtures were related to the solubility of NSAIDs. The pH and polarity were the parameters that most influenced the drugs’ solubility. Ibuprofen, naproxen, ketoprofen, indomethacin, and flurbiprofen did not present any solubility improvement in the formulations tested. However, concentrated mixtures of C:A:W or G:S in the physiologic-mimicked media (PBS) rendered a celecoxib solubility 4 and 5 times higher than PBS, respectively. These therapeutic liquid formulations of celecoxib in C:A:W or G:S can be a promising tool to increase celecoxib’s therapeutic efficiency in local applications.
Description: ERC-2016-CoG 725034
Peer review: yes
URI: http://hdl.handle.net/10362/142606
DOI: https://doi.org/10.3390/pharmaceutics13101620
ISSN: 1999-4923
Appears in Collections:FCT: DQ - Artigos em revista internacional com arbitragem científica

Files in This Item:
File Description SizeFormat 
pharmaceutics_13_01620_v2.pdf2,45 MBAdobe PDFView/Open


FacebookTwitterDeliciousLinkedInDiggGoogle BookmarksMySpace
Formato BibTex MendeleyEndnote 

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.